PTEN loss did not show correlation with PD-L1 expression in prostate and breast cancers, high grade neuroendocrine carcinoma of the lung, pulmonary squamous cell, adenocarcinoma, pulmonary sarcomatoid and endometrial carcinoma [89–94]. The gene discussed is PTEN; the disease is breast carcinoma.